89532-73-0 Usage
Uses
Used in Pharmaceutical Industry:
3-(1H-PYRAZOL-1-YL)PROPANOIC ACID is used as a therapeutic agent for its anti-inflammatory and analgesic properties, primarily for the treatment of conditions such as arthritis and chronic pain. Its pharmacological effects make it a candidate for developing new medications to alleviate inflammation and pain.
Used in Chemical Synthesis:
In the chemical synthesis industry, 3-(1H-PYRAZOL-1-YL)PROPANOIC ACID serves as a key intermediate in the creation of other pharmaceutical compounds. Its unique structure allows for its use in the development of novel drugs with potential applications in various therapeutic areas.
Used in Research and Development:
3-(1H-PYRAZOL-1-YL)PROPANOIC ACID is utilized as a subject of ongoing research to explore its full potential in medical and industrial fields. This includes investigating its mechanisms of action, optimizing its synthesis, and assessing its safety and efficacy for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 89532-73-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,5,3 and 2 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 89532-73:
(7*8)+(6*9)+(5*5)+(4*3)+(3*2)+(2*7)+(1*3)=170
170 % 10 = 0
So 89532-73-0 is a valid CAS Registry Number.
InChI:InChI=1/C6H8N2O2/c9-6(10)2-5-8-4-1-3-7-8/h1,3-4H,2,5H2,(H,9,10)
89532-73-0Relevant academic research and scientific papers
CYCLIC PENTAMER COMPOUNDS AS PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) INHIBITORS FOR THE TREATMENT OF METABOLIC DISORDER
-
Page/Page column 317-318, (2020/06/19)
The disclosure relates to inhibitors of PCSK9 useful in the treatment of cholesterol lipid metabolism, and other diseases in which PCSK9 plays a role, having the Formula (I):, or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, N-oxide, or tautomer thereof, wherein X1, R1, R2, R3, R4, R5, R6, R6', R7, R7', R8, R9, R9', R10, R11, R12, and n are described herein.
Endothelin antagonists
-
, (2008/06/13)
A compound of the formula (I): or a pharmaceutically acceptable salt thereof is disclosed, as well as processes for and intermediates in the preparation thereof, and a method of antagonizing endothelin.
Use of low-volatility pyrazole derivatives having hydrophilic groups as nitrification inhibitors
-
, (2008/06/13)
The present invention provides pyrazole compounds which are useful as nitrification inhibitors.
Novel Parham-type Cycloacylations of 1H-Pyrazole-1-alkanoic Acids
Larsen, Scott D.
, p. 1013 - 1014 (2007/10/03)
Exposure of 1H-pyrazole-1-alkanoic acids to two equivalents of n-butyllithium affords the corresponding cyclic ketones via a Parham-type cyclization process. Although yields are modest, this procedure represents a simple and direct intramolecular acylation of a non-nucleophilic pyrazole carbon.
